85%Confidence
0Views
FDASource
2026-03-06Date
Summary
Asteria Health's testosterone product faces a Class II recall for potential metal particulate contamination, raising concerns about manufacturing quality control. This could damage brand reputation and trigger regulatory scrutiny for the company's sterile products.
Actionable: Assess Asteria Health's manufacturing processes and consider alternative testosterone suppliers.
AI Confidence: 85%
Data Points
firmF.H. INVESTMENTS, Inc. (dba Asteria Health)
classificationClass II
statusOngoing
distributionNationwide in the USA
productTestosterone, 100 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-1100-32.
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now